3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more manageable tariff levels has grown. Trump struck a deal with the U.K. and has signed an initial agreement with China, signs that the impact of tariffs may be limited.And this has helped the S&P 500, (SNPINDEX: ^GSPC), the Nasdaq Composite (NASDAQINDEX: ^IXIC), and the Dow Jones Industrial Average (DJINDICES: ^DJI) rebound from lows. At the same time, many members of these indexes still are trading at reasonable levels, making now a great time to go bargain hunting. In fact, one stock actually bucked the trend of the market, climbing through the worst of the tariff turmoil, but in recent weeks has tumbled, offering us an opportunity to buy on the dip.This stock is Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF) treatment market. The company has slipped 14% in May, though, after an earnings disappointment -- an illegal generic CF drug in Russia hurt sales in the latest quarter. This is not an issue that will disrupt long-term growth, though, so let's check out three reasons why you should buy shares of Vertex like there's no tomorrow.Continue reading
The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more manageable tariff levels has grown. Trump struck a deal with the U.K. and has signed an initial agreement with China, signs that the impact of tariffs may be limited.
And this has helped the S&P 500, (SNPINDEX: ^GSPC), the Nasdaq Composite (NASDAQINDEX: ^IXIC), and the Dow Jones Industrial Average (DJINDICES: ^DJI) rebound from lows. At the same time, many members of these indexes still are trading at reasonable levels, making now a great time to go bargain hunting. In fact, one stock actually bucked the trend of the market, climbing through the worst of the tariff turmoil, but in recent weeks has tumbled, offering us an opportunity to buy on the dip.
This stock is Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF) treatment market. The company has slipped 14% in May, though, after an earnings disappointment -- an illegal generic CF drug in Russia hurt sales in the latest quarter. This is not an issue that will disrupt long-term growth, though, so let's check out three reasons why you should buy shares of Vertex like there's no tomorrow.
